Wednesday, July 8, 2026

biotech · TCR-T Cells · B-ALL · TCRX

TScan Therapeutics

TScan Therapeutics trial registry — 10 ClinicalTrials.gov studies with program phase, status, and indication context.

Waltham, USA HQ
2018 Founded
152 Employees
Public company Type
TCRX · NYSE Ticker
Company details
Status
Public
HQ
Waltham, USA
Founded
2018
Employees
152
Programs
9
Drugs
5
Patents
0
Intelligence · Clinical Trials

TScan Therapeutics clinical trials

Registry index of 10 ClinicalTrials.gov studies linked to TScan Therapeutics programs — each row shows trial ID, program name, phase, status, and indication.

TScan Therapeutics trial registry — 10 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

8 updates

Latest clinical program signals indexed for TScan Therapeutics.

  1. SOC + TSC-100 — Phase 1

    Clinical update
  2. Tcrx T cell — Phase 1

    Clinical update
  3. KXV01 TCR Lentinvivo Injection — Phase 1

    Clinical update
  4. KSX01-TCRT injection — Phase 1

    Clinical update
  5. KSV01 Injection — Phase 1

    Clinical update
  6. KSV01 Injection — Phase 1

    Clinical update
  7. KSH01 injection — Phase 1

    Clinical update
  8. KSH01 injection — Phase 1

    Clinical update

Trial registry

10 studies